Becton, Dickinson and Company

NYSE:BDX

191.58 (USD) • At close September 8, 2025
Bedrijfsnaam Becton, Dickinson and Company
Symbool BDX
Munteenheid USD
Prijs 191.58
Beurswaarde 54,912,000,660
Dividendpercentage 1.58%
52-weken bereik 163.33 - 251.99
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Thomas E. Polen Jr.
Website https://www.bd.com

An error occurred while fetching data.

Over Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters,

Vergelijkbare Aandelen

Zoetis Inc. logo

Zoetis Inc.

ZTS

151.75 USD

HCA Healthcare, Inc. logo

HCA Healthcare, Inc.

HCA

418.1 USD

Cigna Corporation logo

Cigna Corporation

CI

300.89 USD

Edwards Lifesciences Corporation logo

Edwards Lifesciences Corporation

EW

80.21 USD

Boston Scientific Corporation logo

Boston Scientific Corporation

BSX

108.14 USD

Humana Inc. logo

Humana Inc.

HUM

310.38 USD

Stryker Corporation logo

Stryker Corporation

SYK

393.11 USD

Centene Corporation logo

Centene Corporation

CNC

28.84 USD

McKesson Corporation logo

McKesson Corporation

MCK

696.98 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)